Sarcoma, Ewing
Showing 26 - 50 of 1,326
Personalized Home Exercise Program in Bone Tumor Undergoing
Recruiting
- Osteosarcoma
- +3 more
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Mar 21, 2023
Ewing Sarcoma Trial in United States (drug, diagnostic test, other)
Recruiting
- Ewing Sarcoma
- Trabectedin 1 MG [Yondelis]
- +3 more
-
Los Angeles, California
- +5 more
Aug 15, 2022
Sarcoma, Ewing's, Rhabdomyosarcoma, Soft Tissue Sarcoma Trial in Memphis (image-guided radiotherapy)
Active, not recruiting
- Sarcoma, Ewing's
- +3 more
- image-guided radiotherapy
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 4, 2022
Ewing's Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in New York, Dallas (pbi-shRNA™ EWS/FLI1 Type 1 LPX)
Active, not recruiting
- Ewing's Sarcoma
- +6 more
- pbi-shRNA™ EWS/FLI1 Type 1 LPX
-
New York, New York
- +1 more
Mar 14, 2022
Ewing Sarcoma of Bone, Osteosarcoma Trial in Cairo (Tranexamic acid injection, Saline)
Recruiting
- Ewing Sarcoma of Bone
- Osteosarcoma
- Tranexamic acid injection
- Saline
-
Cairo, EgyptChildren's Cancer Hospital Egypt 57357 Cairo, Egypt
Nov 2, 2022
Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha
Recruiting
- Pancreatic Ductal Adenocarcinoma (PDAC)
- +6 more
-
Omaha, NebraskaUrology Cancer Center/XCancer
Nov 29, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)
Recruiting
- Ewing Sarcoma
- +5 more
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
Pediatric Renal Tumor, Metastatic Osteosarcoma, Metastatic Ewing Sarcoma Trial in Birmingham (Indocyanine green)
Recruiting
- Pediatric Renal Tumor
- +5 more
- Indocyanine green
-
Birmingham, United KingdomBirmingham children's hospital
Jun 27, 2022
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
- Cancer
- +7 more
- Blood sampling
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 17, 2022
Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,
Recruiting
- Relapsed Ewing Sarcoma
- +3 more
- Cabozantinib
- +3 more
-
Boston, Massachusetts
- +1 more
Sep 27, 2021
Solid Tumor, Ewing Sarcoma, Ewing's Tumor Metastatic Trial in Dallas (Vigil)
Temporarily not available
- Solid Tumor
- +7 more
- Vigil
-
Dallas, TexasTexas Oncology - Pediatrics
Feb 9, 2022
Ewing Sarcoma, Rhabdomyosarcoma Trial in Boston, Memphis (Olaparib, Temozolomide, Irinotecan)
Recruiting
- Ewing Sarcoma
- Rhabdomyosarcoma
- Olaparib
- +2 more
-
Boston, Massachusetts
- +4 more
Oct 27, 2021
Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)
Active, not recruiting
- Ewing Sarcoma
- +12 more
- Vigil
- +2 more
-
Little Rock, Arkansas
- +16 more
Feb 9, 2022
Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)
Enrolling by invitation
- Ewing Sarcoma
- +8 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Feb 23, 2022
Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)
Recruiting
- Ewing Sarcoma
- +10 more
- Seclidemstat
- +2 more
-
Los Angeles, California
- +16 more
Jan 18, 2022
Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)
Recruiting
- Neuroblastoma
- +5 more
- GD2-CART01
-
Roma, ItalyOspedale Pediatrico Bambino Gesù
Mar 9, 2022
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,
Not yet recruiting
- Solid Tumors
- +8 more
- Magnetic Resonance-Guided High Intensity Focused Ultrasound
- Lyso-thermosensitive Liposomal Doxorubicin
- (no location specified)
Mar 10, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Ewing's Sarcoma (ES) Trial in Italy (TEMIRI, ADM, IFO)
Active, not recruiting
- Ewing's Sarcoma (ES)
- TEMIRI
- +6 more
-
Aviano, Pordenone, Italy
- +12 more
Oct 29, 2021
Solid Tumor, Lymphoma, Osteosarcoma Trial in Orange (Surufatinib in combination with Gemcitabine)
Recruiting
- Solid Tumor
- +5 more
- Surufatinib in combination with Gemcitabine
-
Orange, CaliforniaChildrens Hospital Orange County
Feb 8, 2022
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022